Page last updated: 2024-11-12
subergorgic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
subergorgic acid: isolated from Subergorgia suberosa; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11054000 |
| CHEMBL ID | 453238 |
| MeSH ID | M0292524 |
Synonyms (3)
| Synonym |
|---|
| CHEMBL453238 |
| subergorgic acid |
| (1s,2r,5s,8s,9r)-2,5,9-trimethyl-11-oxotricyclo[6.3.0.01,5]undec-3-ene-3-carboxylic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (5)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID378279 | Cytotoxicity against mouse P388 cells by MTT method | 2000 | Journal of natural products, Dec, Volume: 63, Issue:12 | New cytotoxic sesquiterpenes from the gorgonian Isis hippuris. |
| AID378280 | Cytotoxicity against human A549 cells by MTT method | 2000 | Journal of natural products, Dec, Volume: 63, Issue:12 | New cytotoxic sesquiterpenes from the gorgonian Isis hippuris. |
| AID361125 | Cytotoxicity against human HeLa cells after 4 hrs by MTT assay | 2002 | Journal of natural products, Jul, Volume: 65, Issue:7 | Two new subergane-based sesquiterpenes from a Taiwanese Gorgonian coral Subergorgia suberosa. |
| AID378281 | Cytotoxicity against human HT29 cells by MTT method | 2000 | Journal of natural products, Dec, Volume: 63, Issue:12 | New cytotoxic sesquiterpenes from the gorgonian Isis hippuris. |
| AID361124 | Cytotoxicity against human KB cells after 4 hrs by MTT assay | 2002 | Journal of natural products, Jul, Volume: 65, Issue:7 | Two new subergane-based sesquiterpenes from a Taiwanese Gorgonian coral Subergorgia suberosa. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||